RNA-editing oligonucleotides and uses thereof
US12173285B2 · kind B2 · utility
0Cited by
9References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2023 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | May 9, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/334
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result, e.g., in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.